Preface [Hot Topic:Inflammatory Markers and Mediators: Emerging Therapeutic Targets in Diabetes, Cardiovascular and Metabolic Disorders (Guest Editor: Samuel Dagogo-Jack, MD)].
Journal:
Current Drug Targets
Volume:
4
Page:
iii-iii
Author(s):
Samuel Dagogo-Jack
Novel Cardiovascular Risk Factors and Macrovascular and Microvascular Complications of Diabetes
Journal:
Current Drug Targets
Volume:
4
Page:
477-486
Author(s):
P. Theuma and V. A. Fonseca
Insulin Resistance as a Proinflammatory State: Mechanisms, Mediators, and Therapeutic Interventions
Journal:
Current Drug Targets
Volume:
4
Page:
487-492
Author(s):
Rajesh Garg, Devjit Tripathy and Paresh Dandona
Activated T Lymphocytes in Type 2 Diabetes: Implications From in Vitro Studies
Journal:
Current Drug Targets
Volume:
4
Page:
493-503
Author(s):
Frankie B. Stentz and Abbas E. Kitabchi
Hypertension to Heart Failure: New Developmental Strategies do not Cross a Clinical and Therapeutic Divide
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1665-1678
Author(s):
Robert J. MacFadyen, Gregory Y.H. Lip and Russell Davis
The Prothrombotic State in Hypertension and the Effects of Antihypertensive Treatment
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1715-1732
Author(s):
Sunil Nadar and Gregory Y.H. Lip
Hypertension and Angiogenesis
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1733-1744
Author(s):
F. N. Kiefer, S. Neysari, R. Humar, W. Li, V. C. Munk and E. J. Battegay
Pharmacological Treatment of Hypertension in Pregnancy
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1745-1753
Author(s):
Y. Afifi and D. Churchill
Human Hepatocytes as a Tool for Studying Toxicity and Drug Metabolism
Journal:
Current Drug Metabolism
Volume:
4
Page:
292-312
Author(s):
M. J. Gomez-Lechon, M. T. Donato, J. V. Castell and R. Jover
From Pharmacotherapy to Pathophysiology: Emerging Mechanisms of Apolipoprotein D in Psychiatric Disorders
Journal:
Current Molecular Medicine
Volume:
3
Page:
408-418
Author(s):
E. A. Thomas, D. L. Copolov and J. G. Sutcliffe